Register

Chronic bronchitis

FDA

FDA panel backs inhaler drug for lung disease

WASHINGTON (AP) — A panel of respiratory experts has voted in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravence for treating chronic lung disease.

04/17/2013

Follow

Get every new post delivered to your Inbox.

Join 28,172 other followers